A detailed history of D. E. Shaw & Co., Inc. transactions in Veracyte, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 95,030 shares of VCYT stock, worth $3.84 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
95,030
Holding current value
$3.84 Million
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$21.0 - $35.25 $2 Million - $3.35 Million
95,030 New
95,030 $3.23 Million
Q1 2024

May 15, 2024

BUY
$21.0 - $29.1 $480,900 - $666,390
22,900 New
22,900 $507,000
Q3 2023

Nov 14, 2023

BUY
$22.33 - $29.92 $398,121 - $533,443
17,829 New
17,829 $398,000
Q1 2023

May 15, 2023

BUY
$20.58 - $27.89 $1.61 Million - $2.18 Million
78,190 Added 537.5%
92,737 $2.07 Million
Q4 2022

Feb 14, 2023

SELL
$15.31 - $29.94 $1.15 Million - $2.25 Million
-75,266 Reduced 83.8%
14,547 $345,000
Q3 2022

Nov 14, 2022

BUY
$16.58 - $27.9 $1.49 Million - $2.51 Million
89,813 New
89,813 $1.49 Million
Q4 2021

Feb 14, 2022

SELL
$36.09 - $53.79 $423,624 - $631,387
-11,738 Closed
0 $0
Q3 2021

Nov 15, 2021

SELL
$35.62 - $52.97 $5.51 Million - $8.2 Million
-154,805 Reduced 92.95%
11,738 $545,000
Q2 2021

Aug 16, 2021

SELL
$32.94 - $56.62 $529,049 - $909,373
-16,061 Reduced 8.8%
166,543 $6.66 Million
Q1 2021

May 17, 2021

BUY
$44.47 - $81.38 $6.85 Million - $12.5 Million
153,978 Added 537.9%
182,604 $9.82 Million
Q4 2020

Feb 16, 2021

BUY
$32.49 - $61.88 $930,058 - $1.77 Million
28,626 New
28,626 $1.4 Million
Q3 2019

Nov 14, 2019

SELL
$23.87 - $30.93 $2.87 Million - $3.72 Million
-120,119 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$22.1 - $28.56 $3.76 Million - $4.86 Million
-170,170 Reduced 58.62%
120,119 $3.42 Million
Q1 2019

May 15, 2019

BUY
$12.0 - $25.76 $1.34 Million - $2.88 Million
111,772 Added 62.61%
290,289 $7.26 Million
Q4 2018

Feb 14, 2019

BUY
$9.15 - $14.85 $1.63 Million - $2.65 Million
178,517 New
178,517 $2.25 Million

Others Institutions Holding VCYT

About VERACYTE, INC.


  • Ticker VCYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,575,904
  • Market Cap $2.89B
  • Description
  • Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...
More about VCYT
Track This Portfolio

Track D. E. Shaw & Co., Inc. Portfolio

Follow D. E. Shaw & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.